惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

IT之家
IT之家
Microsoft Azure Blog
Microsoft Azure Blog
人人都是产品经理
人人都是产品经理
博客园 - 聂微东
博客园_首页
阮一峰的网络日志
阮一峰的网络日志
V
V2EX
小众软件
小众软件
F
Fortinet All Blogs
Microsoft Security Blog
Microsoft Security Blog
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
H
Hackread – Cybersecurity News, Data Breaches, AI and More
量子位
Google DeepMind News
Google DeepMind News
Jina AI
Jina AI
让小产品的独立变现更简单 - ezindie.com
让小产品的独立变现更简单 - ezindie.com
aimingoo的专栏
aimingoo的专栏
B
Blog RSS Feed
Cyber Security Advisories - MS-ISAC
Cyber Security Advisories - MS-ISAC
宝玉的分享
宝玉的分享
有赞技术团队
有赞技术团队
J
Java Code Geeks
WordPress大学
WordPress大学
The Cloudflare Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
RaySearch Laboratories AB (publ) (RSLBF) Q1 2026 Earnings...
SA Transcripts · 2026-04-30 · via All Articles on Seeking Alpha

RaySearch Laboratories AB (publ) (RSLBF) Q1 2026 Earnings Call April 29, 2026 5:00 AM EDT

Company Participants

Carolina Stromlid - Head of Investor Relations
Johan Löf - Founder, CEO, President & Director
Nina Grönberg

Conference Call Participants

Kristofer Liljeberg-Svensson - DNB Carnegie, Research Division
Oscar Bergman - Redeye AB, Research Division
Mattias Vadsten - SEB, Research Division

Presentation

Carolina Stromlid
Head of Investor Relations

Welcome to RaySearch presentation of the First Quarter 2026. My name is Carolina Stromlid, and I'm Head of Investor Relations. As usual, our CEO and Founder, Johan Lof; and our CFO, Nina Gronberg, will walk you through the key highlights and financial results of the quarter.

After the presentation, we will open the floor for questions. Simply raise your hand in Teams to ask a question live.

And with that short introduction, I will now hand over to you, Johan.

Johan Löf
Founder, CEO, President & Director

Thank you, Carolina, and welcome again, everyone. I apologize for my voice. I have a cold, as you can tell. Before we dive into the results and highlights, let me start with a quick overview of RaySearch business.

So RaySearch is a pure software company, and we focus on software for cancer treatment. And we have 4 different platforms, RayStation, RayCare, RayIntelligence and RayCommand. What we see here is a schematic view of a comprehensive cancer center. Although RaySearch has been focused on radiation therapy for the first 25 years, we are now about to expand into the other areas of cancer therapy into chemotherapy, surgery and liver ablation, for example. So everything that goes on in a comprehensive cancer center will be supported by RaySearch software in the future.

I think it's important to look at the long-term performance of RaySearch. This diagram shows the revenue all the way back from 2008. And